On 6th February, the Collaborative hosted a webinar with The Global Health Network on "Returning to the Principles of Good Randomized Clinical Trials". A recording of the event is now available online.
Highlights of this edition include an upcoming webinar hosted by the Good Clinical Trials Collaborative and The Global Health Network and the Collaborative’s recommendations to WHO and ICH clinical trials guidance consultations.
On 27 September, the Good Clinical Trials Collaborative submitted its commentary on the draft Good Clinical Practice (GCP) E6R(3) guidelines to the European Medicines Agency (EMA), in response to the public consultation launched by the International Council of Harmonisation of Technical Requirements for Pharmaceuticals for Human…
In August, the Good Clinical Trials Collaborative and four major clinical trials networks unveiled a strategic collaboration aimed at bolstering clinical trials research in low- and middle-income countries. In a new article in Clinical Leader, Nick Medhurst delves into how Good Trials Prism can play…
The Good Clinical Trials Collaborative has submitted feedback on the World Health Organization’s draft clinical trials best practice guidance, in response to its public consultation launched in July 2023.
The Good Clinical Trials Collaborative has submitted commentaries to national regulatory authorities, responding to the public consultation launched by the International Council of Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) in May 2023.
Highlights of this edition include World Health Organization’s public consultation of its draft clinical trials guidance and Professor Sir Martin Landray's participation in NIH Pragmatic Trials Collaboratory's webinar on Friday, 18 August, discussing International Council of Harmonisation’s updated guidelines for Good Clinical Practice.
Four major clinical trial networks based in low resource settings and the Good Clinical Trials Collaborative have formed Good Trials Prism - an exciting partnership to enhance clinical research in low resource settings.